[1]卢海霞,覃柞莲,陆丽娟,等.黄芪甲苷抗肾纤维化的相关分子机制研究[J].西部中医药,2022,35(03):145-151.[doi:10.12174/j.issn.2096-9600.2022.03.34]
 LU Haixia,QIN Zuolian,LU Lijuan,et al.Advances in Molecular Mechanism of Astragaloside IV on Renal Fibrosis[J].Western Journal of Traditional Chinese Medicine,2022,35(03):145-151.[doi:10.12174/j.issn.2096-9600.2022.03.34]
点击复制

黄芪甲苷抗肾纤维化的相关分子机制研究
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年03期
页码:
145-151
栏目:
研究进展
出版日期:
2022-03-15

文章信息/Info

Title:
Advances in Molecular Mechanism of Astragaloside IV on Renal Fibrosis
作者:
卢海霞, 覃柞莲, 陆丽娟, 吴炳瑶, 谢丽, 李丽
广西中医药大学第一附属医院,广西 南宁 530001
Author(s):
LU Haixia, QIN Zuolian, LU Lijuan, WU Bingyao, XIE Li, LI Li
The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530001, China
关键词:
肾纤维化分子机制黄芪甲苷综述
Keywords:
renal fibrosismolecular mechanismastragaloside IVreview
分类号:
R256
DOI:
10.12174/j.issn.2096-9600.2022.03.34
文献标志码:
A
摘要:
通过综述肾纤维化的发生机制、黄芪甲苷(astragaloside IV,AS-IV)抗肾间质纤维化的分子机制及含AS-IV的抗肾纤维进程的相关中成药及注射剂探讨AS-IV抗肾纤维化的相关分子机制研究进展,指出已有研究证实AS-IV主要通过剂量依赖等方式阻止及防范足细胞凋亡及抑制肾脏纤维化。
Abstract:
Research progress on molecular mechanism of AS-IV against renal fibrosis was discussed by reviewing the pathogenesis of renal fibrosis, molecular mechanism of AS-IV on renal interstitial fibrosis, the related Chinese patent medicine and injections containing AS-IV against the progression of renal fibrosis. The previous studies have confirmed that AS mainly prevent podocyte apoptosis and inhibit renal fibrosis in a dose-dependent manner.

相似文献/References:

[1]邹荣,肖方喜,熊飞,等.肾衰合剂通过PKA信号通路抑制肾纤维化的实验观察[J].西部中医药,2015,28(06):4.[doi:2015/6/16 0:00:00]
[2]晁旭,李宏,王国全,等.贝母素乙诱导人肝癌SMMC-7721细胞凋亡的分子机制研究[J].西部中医药,2020,33(03):26.[doi:10.12174/j.issn.1004-6852.2020.03.07]
 CHAO Xu,LI Hong,et al.Research on Molecular Mechanism of the Apoptosis of Human Liver Cancer SMMC-7721 Cells Induced by Peiminine[J].Western Journal of Traditional Chinese Medicine,2020,33(03):26.[doi:10.12174/j.issn.1004-6852.2020.03.07]
[3]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
 SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(03):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[4]盖银玲,王媛媛,杨小春,等.芪实益肾方联合缬沙坦治疗慢性肾小球肾炎的疗效及对炎症因子、肾纤维化指标的影响[J].西部中医药,2022,35(05):119.[doi:10.12174/j.issn.2096-9600.2022.05.27]
 GAI Yinling,WANG Yuanyuan,YANG Xiaochun,et al.Clinical Effects of Qishi Benefiting-kidney Prescription in Combination with Valsartan in the Treatment of Chronic Glomerulonephritis and Its Influence on Inflammatory Factors and Renal Fibrosis Indexes[J].Western Journal of Traditional Chinese Medicine,2022,35(03):119.[doi:10.12174/j.issn.2096-9600.2022.05.27]
[5]郑丹如,卢海霞,许禄华,等.八珍汤促宫颈成熟分子机制和生物通路的网络药理学研究[J].西部中医药,2021,34(11):56.[doi:10.12174/j.issn.2096-9600.2021.11.12]
 ZHENG Danru,LU Haixia,XU Luhua,et al.Network Pharmacological Study on Molecular Mechanism and Biological Pathway of Bazhen Decoction in Promoting Cervical Maturation[J].Western Journal of Traditional Chinese Medicine,2021,34(03):56.[doi:10.12174/j.issn.2096-9600.2021.11.12]
[6]温明韬,梁学振,许波,等.基于网络药理学探讨杜仲-牛膝治疗股骨头坏死的分子机制[J].西部中医药,2021,34(08):76.[doi:10.12174/j.issn.2096-9600.2021.08.17]
 WEN Mingtao,LIANG Xuezhen,XU Bo,et al.Molecular Mechanism of Duzhong-niuxi in Treating Osteonecrosis of the Femoral Head Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2021,34(03):76.[doi:10.12174/j.issn.2096-9600.2021.08.17]
[7]马思遥,任延毅,王雪冰.基于复杂网络技术分析“北沙参-桔梗”治疗放射性肺炎的机制[J].西部中医药,2023,36(05):17.[doi:10.12174/j.issn.2096-9600.2023.05.04]
 MA Siyao,REN Yanyi,WANG Xuebing.The Mechanism of "Beishashen-Jiegeng" for the Treatment of Radiation Pneumonia Based on Complex Network[J].Western Journal of Traditional Chinese Medicine,2023,36(03):17.[doi:10.12174/j.issn.2096-9600.2023.05.04]
[8]许海燕,刘艳红,王珊,等.基于网络药理学探讨百合知母汤抗焦虑与失眠的分子机制[J].西部中医药,2024,37(01):48.[doi:10.12174/j.issn.2096-9600.2024.01.12]
 XU Haiyan,LIU Yanhong,WANG Shan,et al.Molecular Mechanism of Baihe Zhimu Tang against Anxiety and Insomnia Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2024,37(03):48.[doi:10.12174/j.issn.2096-9600.2024.01.12]
[9]张正则,马吉智,孙然,等.基于网络药理学和分子对接技术探讨苍膝通痹胶囊治疗骨关节炎的作用机制[J].西部中医药,2024,37(01):70.[doi:10.12174/j.issn.2096-9600.2024.01.16]
 ZHANG Zhengze,MA Jizhi,SUN Ran,et al.Study on Cangxi Tongbi Capsules in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2024,37(03):70.[doi:10.12174/j.issn.2096-9600.2024.01.16]
[10]马世河,惠普晟,龙漫.基于网络药理学及分子对接技术探究黄连解毒汤治疗脓毒症的分子机制[J].西部中医药,2024,37(02):54.[doi:10.12174/j.issn.2096-9600.2024.02.12]
 MA Shihe,HUI Pusheng,LONG Man.Molecular Mechanism of the Treatment of Sepsis with Huanglian Jiedu Decoction Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2024,37(03):54.[doi:10.12174/j.issn.2096-9600.2024.02.12]

备注/Memo

备注/Memo:
卢海霞(1984—),女,主管护师。研究方向:肾病肾纤维的护理研究。
更新日期/Last Update: 2022-06-24